Mustafa M. Shokr

Sinai University Arish Branch
Arish, SIN 45511, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Prenatal paracetamol exposure and autism spectrum disorder: A critical review of proposed mechanisms, epidemiological evidence, and causal inference.

Prenatal paracetamol exposure and autism spectrum disorder: A critical review of proposed mechanisms, epidemiological evidence, and causal inference.

Journal: Neurotoxicology
Published: June 28, 2026

The gut-brain-mitophagy axis: Urolithin A as a transcriptional activator of Parkin in Alzheimer's and Parkinson's diseases.

The gut-brain-mitophagy axis: Urolithin A as a transcriptional activator of Parkin in Alzheimer's and Parkinson's diseases.

Journal: Molecular and cellular neurosciences
Published: June 28, 2026

Plant-derived Natural Products in Neurological and Psychiatric Disorders: Mechanisms of Action and Synergistic Roles with Probiotics.

Plant-derived Natural Products in Neurological and Psychiatric Disorders: Mechanisms of Action and Synergistic Roles with Probiotics.

Journal: Molecular neurobiology
Published: May 11, 2026

The endothelin-1/TLR4/NF-κB/NLRP3 inflammasome axis in preeclampsia: a review of a pathological feed-forward loop and therapeutic frontier.

The endothelin-1/TLR4/NF-κB/NLRP3 inflammasome axis in preeclampsia: a review of a pathological feed-forward loop and therapeutic frontier.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 09, 2026

Beyond immune checkpoint blockade: T cell engagers and antibody-drug conjugates in cancer and autoimmune disease.

Beyond immune checkpoint blockade: T cell engagers and antibody-drug conjugates in cancer and autoimmune disease.

Journal: Biochemical pharmacology
Published: May 04, 2026

The mTOR/AMPK signaling axis in placental dysfunction and preeclampsia: mechanisms and therapeutic targeting with metformin.

The mTOR/AMPK signaling axis in placental dysfunction and preeclampsia: mechanisms and therapeutic targeting with metformin.

Journal: Molecular biology reports
Published: March 30, 2026

Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential.

Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential.

Journal: Neuroscience
Published: March 08, 2026

Hyperemesis gravidarum revisited: from GDF15 biology to precision multimodal therapy.

Hyperemesis gravidarum revisited: from GDF15 biology to precision multimodal therapy.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 23, 2026

Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination.

Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination.

Journal: Neuropharmacology
Published: February 09, 2026

Purinergic modulation in Parkinson's disease: the dual role of istradefylline in motor and cognitive outcomes.

Purinergic modulation in Parkinson's disease: the dual role of istradefylline in motor and cognitive outcomes.

Journal: Purinergic signalling
Published: February 02, 2026

From insult to hyperexcitability: pharmacological targeting of MyD88 and JAK/STAT3 pathways in epilepsy.

From insult to hyperexcitability: pharmacological targeting of MyD88 and JAK/STAT3 pathways in epilepsy.

Journal: Inflammopharmacology
Published: February 02, 2026

Clemastine ameliorates ulcerative colitis-induced cognitive impairment by restoring PI3K/Akt/GSK-3β signaling and suppressing ferroptosis.

Clemastine ameliorates ulcerative colitis-induced cognitive impairment by restoring PI3K/Akt/GSK-3β signaling and suppressing ferroptosis.

Journal: Inflammopharmacology
Published: January 28, 2026
Showing 1-12 of 41

Last Updated: 09/26/2026